Dual Role of Peroxiredoxin I in Macrophage-derived Foam Cells*

We and others have shown that foam cell formation initiated by exposing macrophages to oxidized low density lipoprotein (oxLDL) triggers the differential expression of a number of proteins. Specifically, our experiments have identified peroxiredoxin I (Prx I) as one of these up-regulated proteins. The peroxiredoxins, a family of peroxidases initially described for their antioxidant capability, have generated recent interest for their potential to regulate signaling pathways. Those studies, however, have not examined peroxiredoxin for a potential dual functionality as both cytoprotective antioxidant and signal modulator in a single, oxidant-stressed system. In this report, we examine the up-regulation of Prx I in macrophages in response to oxLDL exposure and its ability to function as both antioxidant enzyme and regulator of p38 MAPK activation. As an antioxidant, induction of Prx I expression led to improved cell survival following treatment with oxLDL or tert-butyl hydroperoxide. The improved survival coincided with a decrease in measurable reactive oxygen species (ROS), and both the increased survival and reduced ROS were reversed by Prx I small interfering RNA transfection. Additionally, our data show that activation of p38 MAPK in oxLDL-treated macrophages was dependent on the up-regulation of Prx I. Reduction of Prx I expression by small interfering RNA transfection resulted in a significant decrease in p38 MAPK activation, whereas the up-regulation of Prx I expression with either oxLDL or ethoxyquin led to increased p38 MAPK activation. These results are consistent with multiple roles for Prx I in macrophage-derived foam cells that include functionality as both an antioxidant and a regulator of oxidant-sensitive signal transduction.

[1]  M. Kinter,et al.  Proteomic and Transcriptomic Analyses of Macrophages with an Increased Resistance to Oxidized Low Density Lipoprotein (oxLDL)-induced Cytotoxicity Generated by Chronic Exposure to oxLDL* , 2005, Molecular & Cellular Proteomics.

[2]  H. Vaudry,et al.  Beta‐amyloid peptides stimulate endozepine biosynthesis in cultured rat astrocytes , 2005, Journal of neurochemistry.

[3]  A. Vivancos,et al.  A cysteine-sulfinic acid in peroxiredoxin regulates H2O2-sensing by the antioxidant Pap1 pathway. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Dae-Yeul Yu,et al.  Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II , 2005, Nature.

[5]  J. van der Palen,et al.  Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised‐controlled trial , 2005, Journal of internal medicine.

[6]  S. Rhee,et al.  Reduction of Cysteine Sulfinic Acid by Sulfiredoxin Is Specific to 2-Cys Peroxiredoxins* , 2005, Journal of Biological Chemistry.

[7]  L. Norgren,et al.  The chemokine and scavenger receptor CXCL16/SR-PSOX is expressed in human vascular smooth muscle cells and is induced by interferon gamma. , 2004, Biochemical and biophysical research communications.

[8]  James L. Abbruzzese,et al.  Protein Expression Profiles in Pancreatic Adenocarcinoma Compared with Normal Pancreatic Tissue and Tissue Affected by Pancreatitis as Detected by Two-Dimensional Gel Electrophoresis and Mass Spectrometry , 2004, Cancer Research.

[9]  S. Rhee,et al.  Characterization of Mammalian Sulfiredoxin and Its Reactivation of Hyperoxidized Peroxiredoxin through Reduction of Cysteine Sulfinic Acid in the Active Site to Cysteine* , 2004, Journal of Biological Chemistry.

[10]  Y. Ogawa,et al.  Prevention of hydrogen peroxide-induced apoptosis of human peripheral T cells by a lysosomotropic iron chelator, ammonium chloride. , 2004, International journal of molecular medicine.

[11]  Kap-Seok Yang,et al.  Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  B. Morgan,et al.  A 2-Cys peroxiredoxin regulates peroxide-induced oxidation and activation of a stress-activated MAP kinase. , 2004, Molecular cell.

[13]  S. Kang,et al.  Cytosolic Peroxiredoxin Attenuates The Activation Of Jnk And P38 But Potentiates That Of Erk In Hela Cells Stimulated With Tumor Necrosis Factor-α* , 2004, Journal of Biological Chemistry.

[14]  Kap-Seok Yang,et al.  Reversible Oxidation of the Active Site Cysteine of Peroxiredoxins to Cysteine Sulfinic Acid , 2003, Journal of Biological Chemistry.

[15]  T. Kietzmann,et al.  Phorbol Ester-dependent Activation of Peroxiredoxin I Gene Expression via a Protein Kinase C, Ras, p38 Mitogen-activated Protein Kinase Signaling Pathway* , 2003, Journal of Biological Chemistry.

[16]  R. Morton,et al.  Lipid Transfer Inhibitor Protein Defines the Participation of High Density Lipoprotein Subfractions in Lipid Transfer Reactions Mediated by Cholesterol Ester Transfer Protein (CETP)* , 2003, Journal of Biological Chemistry.

[17]  H. J. Kim,et al.  Preferential elevation of Prx I and Trx expression in lung cancer cells following hypoxia and in human lung cancer tissues , 2003, Cell Biology and Toxicology.

[18]  A. van Dorsselaer,et al.  Regeneration of Peroxiredoxins during Recovery after Oxidative Stress , 2003, Journal of Biological Chemistry.

[19]  B. Brüne,et al.  Induced expression of manganese superoxide dismutase by non-toxic concentrations of oxidized low-density lipoprotein (oxLDL) protects against oxLDL-mediated cytotoxicity. , 2003, The Biochemical journal.

[20]  S. Oikawa,et al.  Mitochondrial peroxiredoxin‐3 protects hippocampal neurons from excitotoxic injury in vivo , 2003, Journal of neurochemistry.

[21]  J. König,et al.  Reaction Mechanism of Plant 2-Cys Peroxiredoxin , 2003, Journal of Biological Chemistry.

[22]  P. Gressens,et al.  Recombinant peroxiredoxin 5 protects against excitotoxic brain lesions in newborn mice. , 2003, Free radical biology & medicine.

[23]  A. Chait,et al.  Induction of Glutathione Synthesis in Macrophages by Oxidized Low-Density Lipoproteins Is Mediated by Consensus Antioxidant Response Elements , 2003, Circulation research.

[24]  J. de Vellis,et al.  Induction of radioprotective peroxiredoxin‐I by ionizing irradiation , 2002, Journal of neuroscience research.

[25]  E. Prochownik,et al.  Pag, a Putative Tumor Suppressor, Interacts with the Myc Box II Domain of c-Myc and Selectively Alters Its Biological Function and Target Gene Expression* , 2002, The Journal of Biological Chemistry.

[26]  Sue Goo Rhee,et al.  Inactivation of Human Peroxiredoxin I during Catalysis as the Result of the Oxidation of the Catalytic Site Cysteine to Cysteine-sulfinic Acid* , 2002, The Journal of Biological Chemistry.

[27]  C. Chignell,et al.  Photosensitized oxidation of 2',7'-dichlorofluorescin: singlet oxygen does not contribute to the formation of fluorescent oxidation product 2',7'-dichlorofluorescein. , 2002, Free radical biology & medicine.

[28]  A. van Dorsselaer,et al.  A method for detection of overoxidation of cysteines: peroxiredoxins are oxidized in vivo at the active-site cysteine during oxidative stress. , 2002, The Biochemical journal.

[29]  Keesook Lee,et al.  Differential expression of Prx I and II in mouse testis and their up-regulation by radiation. , 2002, Biochemical and biophysical research communications.

[30]  R. Aebersold,et al.  Proteomics Analysis of Cellular Response to Oxidative Stress , 2002, The Journal of Biological Chemistry.

[31]  S. Goff,et al.  Pathways of Induction of Peroxiredoxin I Expression in Osteoblasts , 2002, The Journal of Biological Chemistry.

[32]  B. Brüne,et al.  Dualism of Oxidized Lipoproteins in Provoking and Attenuating the Oxidative Burst in Macrophages: Role of Peroxisome Proliferator-Activated Receptor-γ1 , 2002, The Journal of Immunology.

[33]  T. Teramoto,et al.  Synergically increased expression of CD36, CLA-1 and CD68, but not of SR-A and LOX-1, with the progression to foam cells from macrophages. , 2002, Journal of atherosclerosis and thrombosis.

[34]  J. Chang,et al.  Augmented expression of peroxiredoxin I in lung cancer. , 2001, Biochemical and biophysical research communications.

[35]  A. Gotto,et al.  Oxidized Low Density Lipoprotein Decreases Macrophage Expression of Scavenger Receptor B-I* , 2001, The Journal of Biological Chemistry.

[36]  D. Noh,et al.  Overexpression of peroxiredoxin in human breast cancer. , 2001, Anticancer research.

[37]  G. Lupo,et al.  t-Butyl hydroperoxide and oxidized low density lipoprotein enhance phospholipid hydrolysis in lipopolysaccharide-stimulated retinal pericytes. , 2001, Biochimica et biophysica acta.

[38]  Y. Yoo,et al.  Increased expression of peroxiredoxin II confers resistance to cisplatin. , 2001, Anticancer research.

[39]  Y. Twu,et al.  Tumor Necrosis Factor-α-mediated Protein Kinases in Regulation of Scavenger Receptor and Foam Cell Formation on Macrophage* , 2000, The Journal of Biological Chemistry.

[40]  M. Mattson,et al.  In Vivo 2-Deoxyglucose Administration Preserves Glucose and Glutamate Transport and Mitochondrial Function in Cortical Synaptic Terminals after Exposure to Amyloid β-Peptide and Iron: Evidence for a Stress Response , 2000, Experimental Neurology.

[41]  Andrew C. Li,et al.  Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma. , 2000, The Journal of clinical investigation.

[42]  Patrick Griffin,et al.  Peroxynitrite reductase activity of bacterial peroxiredoxins , 2000, Nature.

[43]  G. Pei,et al.  Lysophosphatidylcholine activates p38 and p42/44 mitogen-activated protein kinases in monocytic THP-1 cells, but only p38 activation is involved in its stimulated chemotaxis. , 2000, Circulation research.

[44]  S. Colquhoun,et al.  Induction of peroxiredoxins in transplanted livers and demonstration of their in vitro cytoprotection activity. , 2000, Antioxidants & redox signaling.

[45]  A. Gotto,et al.  Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. , 2000, Journal of lipid research.

[46]  R. van Wijk,et al.  Stimulation of survival capacity in heat shocked cells by subsequent exposure to minute amounts of chemical stressors; role of similarity in hsp-inducing effects , 1999, Human & experimental toxicology.

[47]  G. Pei,et al.  Activation of p38 mitogen-activated protein kinase by oxidized LDL in vascular smooth muscle cells: mediation via pertussis toxin-sensitive G proteins and association with oxidized LDL-induced cytotoxicity. , 1999, Circulation research.

[48]  V. I. Novoselov,et al.  Identification of a 28 kDa secretory protein from rat olfactory epithelium as a thiol-specific antioxidant. , 1998, Free radical biology & medicine.

[49]  Jihong Han,et al.  Lipoproteins modulate expression of the macrophage scavenger receptor. , 1998, The American journal of pathology.

[50]  R. Osathanondh,et al.  Human ventricular myocytes in vitro exhibit both early and delayed preconditioning responses to simulated ischemia. , 1998, Journal of molecular and cellular cardiology.

[51]  D. Steinberg,et al.  Minimally oxidized low-density lipoprotein increases expression of scavenger receptor A, CD36, and macrosialin in resident mouse peritoneal macrophages. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[52]  S. Rhee,et al.  Mammalian Peroxiredoxin Isoforms Can Reduce Hydrogen Peroxide Generated in Response to Growth Factors and Tumor Necrosis Factor-α* , 1998, The Journal of Biological Chemistry.

[53]  R. V. van Etten,et al.  The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. , 1997, Genes & development.

[54]  Jihong Han,et al.  Native and Modified Low Density Lipoproteins Increase the Functional Expression of the Macrophage Class B Scavenger Receptor, CD36* , 1997, The Journal of Biological Chemistry.

[55]  R. Dean,et al.  Sterol Efflux Is Impaired from Macrophage Foam Cells Selectively Enriched with 7-Ketocholesterol* , 1996, The Journal of Biological Chemistry.

[56]  E. Stadtman,et al.  Removal of Hydrogen Peroxide by Thiol-specific Antioxidant Enzyme (TSA) Is Involved with Its Antioxidant Properties , 1996, The Journal of Biological Chemistry.

[57]  A. Tall,et al.  Interleukin 8 Is Induced by Cholesterol Loading of Macrophages and Expressed by Macrophage Foam Cells in Human Atheroma (*) , 1996, The Journal of Biological Chemistry.

[58]  T. Ishii,et al.  Inhibition of the thiol-specific antioxidant activity of rat liver MSP23 protein by hemin. , 1995, Biochemical and biophysical research communications.

[59]  E. Gallagher,et al.  Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz. , 1995, Toxicology and applied pharmacology.

[60]  P. Libby,et al.  Components of the protein fraction of oxidized low density lipoprotein stimulate interleukin-1 alpha production by rabbit arterial macrophage-derived foam cells. , 1995, Journal of lipid research.

[61]  J. Pearson,et al.  Induction of the antioxidant stress proteins heme oxygenase‐1 and MSP23 by stress agents and oxidised LDL in cultured vascular smooth muscle cells , 1995, FEBS letters.

[62]  A. Nègre-Salvayre,et al.  Phospholipid hydrolysis of mildly oxidized LDL reduces their cytotoxicity to cultured endothelial cells. Potential protective role against atherogenesis. , 1995, Biochimica et biophysica acta.

[63]  T. Ishii,et al.  Cloning and characterization of a 23-kDa stress-induced mouse peritoneal macrophage protein. , 1993, The Journal of biological chemistry.

[64]  U. Steinbrecher,et al.  Effects of oxidatively modified LDL on cholesterol esterification in cultured macrophages. , 1990, Journal of lipid research.

[65]  U. Steinbrecher,et al.  Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation. , 1989, The Journal of biological chemistry.

[66]  D. Steinberg,et al.  Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[67]  D. Steinberg,et al.  Decrease in Reactive Amino Groups during Oxidation or Endothelial Cell Modification of LDL: Correlation with Changes in Receptor‐Mediated Cataboiism , 1987, Arteriosclerosis.

[68]  D. Steinberg,et al.  Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[69]  S. Glagov,et al.  Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. , 1980, The American journal of pathology.

[70]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[71]  F. Matsumura,et al.  Activation of inflammatory mediators and potential role of Ah-receptor ligands in foam cell formation , 2007, Cardiovascular Toxicology.

[72]  Gerrity Rg,et al.  Ultrastructural identification of monocyte-derived foam cells in fatty streak lesions. , 1980 .

[73]  C. Wanner,et al.  J Am Soc Nephrol 11: 1819–1825, 2000 Stimulation of NADPH Oxidase by Oxidized Low-Density Lipoprotein Induces Proliferation of Human Vascular , 2022 .

[74]  T. Ishii,et al.  Macrophages : Activation by Oxidatively Modified Ldl and 4-hydroxynonenal Role of Nrf2 in the Regulation of Cd36 and Stress Protein Expression in Murine , 2022 .